The tumour-inhibiting potential of the progesterone antagonist Onapristone in the human mammary carcinoma T61 in nude mice

1992 ◽  
Vol 118 (3) ◽  
pp. 187-189 ◽  
Author(s):  
Martin R. Schneider ◽  
Horst Michna ◽  
Ursula-F. Habenicht ◽  
Yukishige Nishino ◽  
Hans J�rg Grill ◽  
...  
1994 ◽  
Vol 48 (2-3) ◽  
pp. 187-196 ◽  
Author(s):  
P. Van de Velde ◽  
F. Nique ◽  
F. Bouchoux ◽  
J. Brémaud ◽  
M-C. Hameau ◽  
...  

1993 ◽  
Vol 119 (11) ◽  
pp. 652-656 ◽  
Author(s):  
Helga Naundorf ◽  
Iduna Fichtner ◽  
Gerd J�rg Saul ◽  
Wolfgang Haensch ◽  
Britta B�ttner

2002 ◽  
Vol 103 (2) ◽  
pp. 268-276 ◽  
Author(s):  
Mathieu Gutman ◽  
Steeve Couillard ◽  
Fernand Labrie ◽  
Bernard Candas ◽  
Claude Labrie

Author(s):  
John H.L. Watson ◽  
John L. Swedo ◽  
R.W. Talley

A preliminary study of human mammary carcinoma on the ultrastructural level is reported for a metastatic, subcutaneous nodule, obtained as a surgical biopsy. The patient's tumor had responded favorably to a series of hormonal therapies, including androgens, estrogens, progestins, and corticoids for recurring nodules over eight years. The pertinent nodule was removed from the region of the gluteal maximus, two weeks following stilbestrol therapy. It was about 1.5 cms in diameter, and was located within the dermis. Pieces from it were fixed immediately in cold fixatives: phosphate buffered osmium tetroxide, glutaraldehyde, and paraformaldehyde. Embedment in each case was in Vestopal W. Contrasting was done with combinations of uranyl acetate and lead hydroxide.


Sign in / Sign up

Export Citation Format

Share Document